| 1 |
Kapil Gulati |
Qualcomm |
765 |
| 2 |
Hao Zhang |
Bristol-Myers Squibb |
111 |
| 3 |
Frederick J. Karol |
Union Carbide Chemicals & Plastics Technology |
89 |
| #4 |
Li Fan |
Edda Technology |
79 |
| #5 |
Yufeng Wang |
Bristol-Myers Squibb |
78 |
| #6 |
Young-Choon Moon |
Ptc Therapeutics |
63 |
| #7 |
Ravi K. Varma |
E.R. Squibb & Sons. |
62 |
| #8 |
Barry K. Speronello |
Engelhard |
58 |
| #9 |
Xiaoyan Zhang |
Biomed Valley Discoveries |
54 |
| #10 |
Carlino Panzera |
Jeneric/Pentron Incorporated |
50 |
| #11 |
William V. Murray |
Ortho Pharmaceutical |
49 |
| #12 |
Richard J. McPartland |
Agere Systems |
48 |
| #12 |
Robert Falotico |
Cordis |
48 |
| #14 |
Yoon Jeon |
Bristol-Myers Squibb |
46 |
| #15 |
Jonathon Z. Zhao |
Cordis |
45 |
| #16 |
Guanghui Zhang |
Johnson & Johnson |
44 |
| #16 |
Ying Wang |
Bristol-Myers Squibb |
44 |
| #18 |
Joel E. Bernstein |
Elorac |
43 |
| #19 |
Michael J. Fevola |
Johnson & Johnson |
42 |
| #20 |
Joseph H. Kang |
Alcatel Lucent |
40 |
| #20 |
Shiv Kumar |
Columbia University |
40 |
| #22 |
Gueyoung Jung |
Xerox |
38 |
| #22 |
Rajeev Farwaha |
National Starch And Chemical Investment Holding Copporation |
38 |
| #24 |
Zhengming Chen |
Purdue Pharma |
37 |
| #24 |
Soongyu Choi |
Ptc Therapeutics |
37 |
| #26 |
Guoqing Li |
Merck |
36 |
| #27 |
Hai-Yun Xiao |
Bristol-Myers Squibb |
35 |
| #28 |
Pranav Ashar |
— |
33 |
| #29 |
Chung Wai Leung |
AT&T |
31 |
| #29 |
Prithwiraj Maitra |
Johnson & Johnson |
31 |
| #29 |
Ruth R. Wexler |
Bristol-Myers Squibb |
31 |
| #32 |
Roger W. Lehmann |
Universitat Zurich |
30 |
| #32 |
Richard Scott Robinson |
Colgate-Palmolive |
30 |
| #32 |
Chuansheng Ge |
Bristol-Myers Squibb |
30 |
| #32 |
Subir Das |
Telcordia Technologies |
30 |
| #36 |
Salvatore Caldarise |
Johnson & Johnson |
29 |
| #36 |
John J. Tsai |
National Starch And Chemical Investment Holding Copporation |
29 |
| #36 |
Jian Jim Wang |
Unknown |
29 |
| #39 |
Victor Katsap |
Nuflare Technology |
27 |
| #39 |
Halou Oumar-Mahamat |
ExxonMobil |
27 |
| #41 |
Chunlin Yang |
Johnson & Johnson |
26 |
| #41 |
Robert F. Eaton |
Dow Global Technologies |
26 |
| #43 |
William A. Slusarchyk |
E.R. Squibb & Sons. |
25 |
| #44 |
Shaw-Chang Chu |
ExxonMobil |
24 |
| #44 |
Nilgun E. Tumer |
— |
24 |
| #44 |
Chang-Sun Lee |
Ptc Therapeutics |
24 |
| #44 |
Zhen-Wei Cai |
Bristol-Myers Squibb |
24 |
| #48 |
Govindan Subramanian |
Novo Nordisk A/S |
23 |
| #48 |
Ming Wang |
Bayer Pharmaceuticals |
23 |
| #48 |
Robert Maurer |
Johnson & Johnson |
23 |